Error: Can't connect Warning: mysqli_query() expects parameter 1 to be mysqli, null given in /home/customer/www/hsfnotes.com/public_html/wp-content/themes/hsfnotes/template-parts/tpl_filters.php on line 186
Warning: mysqli_fetch_assoc() expects parameter 1 to be mysqli_result, null given in /home/customer/www/hsfnotes.com/public_html/wp-content/themes/hsfnotes/template-parts/tpl_filters.php on line 187
We are delighted that our overviews of regulatory and competition law in the EU and South Africa have now been published as jurisdictional contributions to the Lexology Getting the Deal Through Pharmaceutical Antitrust guide. The online publication serves as a quick reference guide enabling side-by-side comparison of local insights into pharmaceutical regulatory law (framework, authorities, … Read more
On 20 April 2022 the UK government published its response to the consultation launched in July 2021, proposing a wide range of far-reaching changes to the UK competition and consumer protection regimes (see our blog post on the consultation here). Taking into account the feedback received from stakeholders on the various proposals, the government has … Read more
We are delighted that our overview of recent activity, reforms and trends in relation to antitrust enforcement in the Asia-Pacific region has been published as part of the Global Competition Review Asia-Pacific Antitrust Review 2022. Our chapter summarises notable regulatory reforms and enforcement activity across jurisdictions in the Asia-Pacific region. Notwithstanding the COVID-19 pandemic, the … Read more
On 20 July 2021 the UK government launched a consultation on a wide range of far-reaching changes it is proposing to the UK competition and consumer protection regimes. As a result of Brexit the UK is now in a position to decide, independently from the EU Commission, how it promotes and enforces competition law affecting … Read more
On 4 March 2021 the EU Commission announced it has launched a formal investigation into possible anti-competitive conduct by pharmaceutical company Teva in relation to its blockbuster drug Copaxone, which is used in the treatment of multiple sclerosis. Read more
“When the price of a drug suddenly goes up by several hundred percent, this is something the Commission may look at” Commissioner Vestager said when opening a formal investigation into Aspen’s alleged excessive pricing conduct in May 2017. On 10 February 2021, the EU Commission (Commission) closed the investigation by accepting legally binding commitments offered … Read more
On 26 January 2021 the Competition Appeal Tribunal (CAT) published a notice of a standalone competition damages claim (brought under section 47A of the Competition Act 1998) by Kerilee Investments, a metal trader, against the International Tin Association, a UK based trade association. The claimant alleges that the trade association abused its dominant position and … Read more
The German FCO has not lost its appetite to take on major tech companies. Today, it has announced that it has initiated abuse proceedings against Facebook to examine the linkage between Oculus virtual reality products and Facebooks’ social network. Read more
On 24 November 2020, the Court of Justice of the European Union (CJEU) handed down a decision on the applicability of Article 7(2) of Regulation No 1215/2012 (the Brussels Ia Reg) to competition law disputes in a preliminary reference relating to an action by German hotel Wikingerhof GmbH & Co. KG (Wikingerhof) against Booking.com BV … Read more
